Nanobiosensor developed for detecting SARS-CoV-2

Infection and immunity status of the population are considered key parameters for handling pandemics. For this purpose, detecting antigens and antibodies is of great importance. The devices currently used for this purpose—what are known as point-of-care (POC) devices—are one option for rapid screening.